Zum Inhalt

Pediatric Rheumatology

Ausgabe Sonderheft 2/2013 Proceedings of 20th Pediatric Rheumatology European Society (PReS) Congress

Inhalt (423 Artikel)

PReS13-SPK-1478: New developments in our care & understanding of JIA

  • Open Access
  • Invited speaker presentation

L Wedderburn

PReS13-SPK-1082: Catastrophic antiphospholipid syndrome

  • Open Access
  • Invited speaker presentation

R Cervera

PReS13-SPK-1240: New aspects on APS pathogenesis

  • Open Access
  • Invited speaker presentation

PL Meroni

PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?

  • Open Access
  • Poster presentation

S de Leeuw, B Thirugnanabalan, H Varsani, F Warden, N Makengo, J Lewis, A Pesenacker, L Wedderburn

PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment

  • Open Access
  • Poster presentation

MI Gonzalez Fernandez, R Bou, R Silvia, E Iglesias, J Sánchez, V Torrente, J Antón

PReS-FINAL-1006: Autologous bone marrow transplantation in autoimmune, experimental arthritis restores immune homeostasis by renewal of the natural tregs compartment

  • Open Access
  • Poster presentation

T van den Broek, E Delemarre, J Meerding, E Wehrens, F Broere, N Wulffraat, M Boes, B Prakken, F van Wijk

PReS-FINAL-1007: Regulatory T cells functional specialization in JIA

  • Open Access
  • Poster presentation

G Mijnheer, B Prakken, FV Wijk

PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus

  • Open Access
  • Poster presentation

A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri, LR Wedderburn, Y Ioannou

PReS-FINAL-1010: circulating micrornas in traps

  • Open Access
  • Poster presentation

OM Lucherini, M Ferracin, V Fulci, M McDermott, G Merlini, I Muscari, F Magnotti, LJ Dickie, M Galeazzi, M Negrini, CT Baldari, L Obici, R Cimaz, L Cantarini

PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases

  • Open Access
  • Poster presentation

A Souto, N Alvarez, A Barros, L Fernandez, B Lopez, I Calvo

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis

  • Open Access
  • Poster presentation

C Malattia, A Madeo, M Dellepiane, A Pistorio, MB Damasio, S Viola, S Pederzoli, A Beltramo, D Beleva, A Consolaro, A Martini

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis

  • Open Access
  • Poster presentation

D Marafon, A Consolaro, C Ferrari, S Dalprà, A Madeo, A Providenti, C Malattia, N Ruperto, A Civino, A Martini, A Ravelli

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report

  • Open Access
  • Poster presentation

GC Varnier, C Ferrari, A Consolaro, D Marafon, C Pilkington, S Maillard, M Jelusic Drazic, S Dalpra', A Civino, A Martini, A Ravelli

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis

  • Open Access
  • Poster presentation

I Pagnini, G Simonini, T Giani, L Cantarini, R Cimaz

PReS-FINAL-2015: Demographic, clinical and laboratory features of juvenile dermatomyositis in Croatia: retrospective study over the last 22 years

  • Open Access
  • Poster presentation

M Frković, I Malčić, I Rukavina, V Rožmanić, K Markičević, N Turjak, M Jelušić

PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients

  • Open Access
  • Poster presentation

VA Kristensen, S Nielsen, T Herlin, P Mathiesen

PReS-FINAL-2017: Systemic onset juvenile idiopathic arthritis (SOJIA)-a 5-year survey in a pediatric rheumatology department

  • Open Access
  • Poster presentation

A Čengić, A Omerčahić Dizdarević, V Selmanović, S Mesihović Dinarević

PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

A Kozhevnikov, N Pozdeeva, M Konev, M Nikitin, V Larionova, G Novik, M Slyndev

PReS-FINAL-2021: JADAS-CRP instead of JADAS-ESR...results from REUMA.PT

  • Open Access
  • Poster presentation

AF Mourão, MJ Santos, J Melo Gomes, F Martins, JA Costa, F Ramos, I Brito, C Duarte, R Figueira, G Figueiredo, C Furtado, A Lopes, M Oliveira, A Rodrigues, M Salgado, M Sousa, J Branco, J Eurico Fonseca, H Canhão

PReS-FINAL-2023: Uveitis surveillance through lean-six sigma for quality assurance in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

A Patwardhan, K Kelleher, K Jones, S Ardoin, C Spencer

PReS-FINAL-2024: Responsiveness of the juvenile arthritis foot disability index

  • Open Access
  • Poster presentation

AC Esbjörnsson, MD Iversen, EW Broström, S Hagelberg, M André

PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus

  • Open Access
  • Poster presentation

AE Bean, M Al-Obaidi, F Shakley, C Waruiru, D Hawley

PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate

  • Open Access
  • Poster presentation

AE Christensen, L Bistrup, P Toftedal

PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

B Schiappapietra, S Calandra, MC Gallo, R De Marco, V Muratore, S Lanni, A Consolaro, A Martini, A Ravelli

PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

B Hugle, M Olsson, N Fischer, M Herrmann, K Lindblad-Toh, JP Haas

PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies

  • Open Access
  • Poster presentation

CA Guillen Astete, L García Campayo, B Conde Campayo, A Sifuentes Giraldo, ML Gamir Gamir

PReS-FINAL-2034: Α1 - Antitrypsin deficiency in children with arthritis: four cases

  • Open Access
  • Poster presentation

C Pruunsild, J Ilisson

PReS-FINAL-2035: Fatty acid profiling: potential new biomarkers in JIA

  • Open Access
  • Poster presentation

C Boros, WT CHAM, J Fletcher, E Ranieri

PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

C Petri, S Thiel, JC Jensenius, B Kuno-Møller, T Herlin

PReS-FINAL-2037: Association between clinical and microbiological periodontal condition in Colombian patients with juvenile idiophatic arthritis

  • Open Access
  • Poster presentation

C Malagon, C Romero, C Vargas, J De Avila, GI Lafaurie, DM Castillo, AC Mosquera

PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA

  • Open Access
  • Poster presentation

D Mihailova, B Varbanova, S Stefanov, A Teltcharova

PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab

  • Open Access
  • Poster presentation

E Alekseeva, R Denisova, S Valieva, T Bzarova, K Isayeva, T Sleptsova, EA Mitenko, E Chistyakova, A Fetisova

PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

E Rossetto, E Benelli, E Mascheroni, E Berton, A Taddio, L Lepore

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

ES Zholobova, OU Konopelko, MN Nikolaeva, OS Rozvadovskaya

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors

  • Open Access
  • Poster presentation

EB Nordal, L Berntson, K Aalto, S Peltoniemi, S Nielsen, T Herlin, A Fasth, M Rygg

PReS-FINAL-2049: Bone health, muscle strength, activity

  • Open Access
  • Poster presentation

E Sandstedt

PReS-FINAL-2051: The difference of disease's perception by JIA patients and their parents: analysis of the JAMAR questionnaire

  • Open Access
  • Poster presentation

F Vanoni, B Fonjallaz, G Lucie, A von Scheven-Gête, M Hofer

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future

  • Open Access
  • Poster presentation

FH Prince, LW van Suijlekom-Smit

PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

F Falcini, F Marini, D Rigante, F Bertini, G Lepri, S Stagi, M Matucci Cerinic, ML Brandi

PReS-FINAL-2054: Latent tuberculosis infection in patients with juvenile idiopathic arthritis undergoing methotrexate therapy: a longitudinal study with TST and ELISPOT

  • Open Access
  • Poster presentation

F Sztajnbok, NL Boechat, SK Oliveira, SB Ribeiro, MC Rodrigues, C Diniz, FCDN Sztajnbok, CC Sant'Anna

PReS-FINAL-2055: Is there a necessity for patients with JIA to wear orthopedic insoles?

  • Open Access
  • Poster presentation

F Kreuzpointner, M Hartmann, A Schwirtz, JP Haas

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation

  • Open Access
  • Poster presentation

N Aktay Ayaz, G Keskindemirci, N Melikoglu, E Aldemir, G Aydogan

PReS-FINAL-2058: Lipid peroxides, lipophuscin, sulfhydryl groups and TOS in children with JIA

  • Open Access
  • Poster presentation

H Mazur Zielinska, M Zielinski, D Karbowska, L Pilarz, E Birkner

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

N Stepanenko, T Shelepina, I Nikishina

PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice

  • Open Access
  • Poster presentation

SV Arsenyeva, IP Nikishina, MI Kaleda, DL Alekseev, LG Medyntceva, SR Rodionovskaya

PReS-FINAL-2063: Proposed criteria for activity, damage and impact of juvenile idiopathic arthritis associated uveitis: consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)

  • Open Access
  • Poster presentation

I Foeldvari, A Heiligenhaus, J Anton, R Ramanan, C Edelsten, T Saurenmann, B Bodaghi, K Kotaniemi, S Nielsen, E Rabinovich

PReS-FINAL-2065: Oxidative stress is associated to disease activity in a large cohort of JIA at transitional period

  • Open Access
  • Poster presentation

J Wipff, C Deslandre, C Gobeaux, A Kahan, D Borderie

PReS-FINAL-2066: Use of chiropractic care in danish children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

KS Kuhn, AJ Schou, AE Christensen

PReS-FINAL-2068: S100 A8/A9 serum levels reflect disease activity in juvenile idiopathic arthritis-associated uveitis

  • Open Access
  • Poster presentation

K Walscheid, D Holzinger, C Heinz, C Arnold, D Bauer, M Busch, M Hennig, S Wasmuth, J Roth, A Heiligenhaus, D Foell

PReS-FINAL-2069: T cells secreting granulocyte-macrophage colony stimulating factor (GM-CSF) within the inflammed joint originate from an "EX-Th17" population

  • Open Access
  • Poster presentation

K Nistala, C Piper, A Pesenacker, D Bending, B Thirugnanabalan, L Wedderburn

PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison

  • Open Access
  • Poster presentation

L Sawyer, A Diamantopoulos, HI Brunner, F De Benedetti, N Ruperto, F Dejonckheere, C Keane

PReS-FINAL-2073: The usefulness of musculoskeletal ultrasound in monitoring efficacy of intraarticular infliximab therapy in JIA patients

  • Open Access
  • Poster presentation

M Vidovic, M Perica, L Lamot, L Tambic Bukovac, M Harjacek

PReS-FINAL-2074: The role of the probiotic VSL-3 as adjuvant therapy in patients with undifferentiated spondyloarthritis (ERA)

  • Open Access
  • Poster presentation

M Vidovic, M Perica, L Lamot, M Zaninovic, L Tambic Bukovac, M Harjacek

PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis

  • Open Access
  • Poster presentation

MI Kaleda, IP Nikishina, SR Rodionovskaya, AN Shapovalenko

PReS-FINAL-2077: Lung function evaluation in a juvenile idiopathic arthritis cohort

  • Open Access
  • Poster presentation

I Machado Vaz, M Rodrigues, I Azevedo, J Winck, I Brito

PReS-FINAL-2078: Single nucleotide polymorphisms of toll like receptors 2 and 4 in enthesitis related arthritis and oligo and polyarticular juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M Perica, M Perić, M Vidović, L Tambić Bukovac, L Lamot, J Barbić, M Harjaček

PReS-FINAL-2079: Will cooling an arthritic joint cause damage? - an analysis of different cooling methods in patients with jia using thermography

  • Open Access
  • Poster presentation

M König, F Kreuzpointner, M Hartmann, M Georgi, HJ Händel, A Schwirtz, JP Haas

PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M Noergaard, J Svensson, LB Andersen, T Herlin

PReS-FINAL-2083: The rate of malignancy in iranian children with joint manifestations

  • Open Access
  • Poster presentation

N Shafaie, Y Aghighi, SR Raeeskarami, A Malek, MR Nesabi, A Izadpanah, B Nourbakhsh, SH Faghihi, Z Oloomi-Yazdi, P Vosough

PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

N Semolič, N Toplak, J Koder, D Ključevšek, T Avčin

PReS-FINAL-2086: In vitro investigation of the sustained therapeutic effect of etanercept loaded microspheres on human rheumatoid arthritis fibroblast-like synoviocytes

  • Open Access
  • Poster presentation

O Erdemli, S Ozen, C Kocaefe, A Usanmaz, ED Batu, B Atilla, D Keskin, A Tezcaner

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?

  • Open Access
  • Poster presentation

O Yurtsever, K Gulleroglu, US Bayrakci, A Kantar, E Baskin

PReS-FINAL-2208: Sacroilitis with propionibacterium acnes in a child

  • Open Access
  • Poster presentation

C Galeotti, I Koné-Paut

PReS-FINAL-2209: MEFV gene mutations in central and south-eastern European countries

  • Open Access
  • Poster presentation

D Perko, M Debeljak, N Toplak, A Sediva, T Dallos, M Harjaček, M Jelušič, G Ristić, B Dérfalvi, K Mironska, S Rusoniene, D Kuzmanovska, N Kurjane, M Bataneant, T Avčin

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases

  • Open Access
  • Poster presentation

D Konukbay, D Yildiz, C Acikel, D Karaman, B Fidanci, Y Bilginer, I Kone-Pau, J Frenkel, M Gottorno, S Ozen, E Demirkaya

PReS-FINAL-2211: NOD2/CARD15 polymorphisms and clinical features in patients with non-infectious uveitis

  • Open Access
  • Poster presentation

E Marrani, R Cimaz, OM Lucherini, R Caputo, A Vitale, L Cantarini, G Simonini

PReS-FINAL-2212: Mevalonate kinase deficiency: different faces with separate treatments

  • Open Access
  • Poster presentation

P Gençpınar, E Ünsal, B Makay

PReS-FINAL-2213: Validation of inadequate drug response and definition of colchicum resistance in FMF

  • Open Access
  • Poster presentation

E Demirkaya, C Acikel, G Basbozkurt, A Gul, O Kasapcopur, O Aydog, H Erdem, A Duzova, B Kisacik, T Kasifoglu, E Erken, M Tunca, M Sayarlioglu, S Yuksel, F Yildiz, O Donmez, A Berdeli, S Senel, NA Ayaz, A Polat, B Sozer, Y Tabel, S Akar, AM Onat, O Ozkaya, S Emre, N Akinca, G Ozcelik, S Yavuz, S Yesilkaya, F Gok, HM Poyrazoglu, H Direskeneli, S Bakkaloglu, S Erten, A Tufan, B Goker, S Kavukcu, N Cakar, M Saldir, A Delibas, B Makay, A Kısaarslan, SE Unsal, H Ozdogan, R Topaloglu, S Ozen

PReS-FINAL-2214: Validation of new pediatric criteria in diagnosis of Familial Mediterranean Fever in children

  • Open Access
  • Poster presentation

E Baskin, US Bayrakci, N Akyol, K Gulleroglu, A Kantar, O Yurtseven, F Şahin

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany

  • Open Access
  • Poster presentation

F Gohar, M Jeske, P Lohse, T Kallinich, U Neudorf, T Niehues, H Wittkowski, E Lainka, D Foell

PReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register

  • Open Access
  • Poster presentation

F Gohar, E Husmann, PJ Haas, G Horneff, H Wittkowski, D Holzinger, T Kallinich, U Neudorf, T Niehues, E Lainka, D Foell

PReS-FINAL-2217: Atypical presentation of CRMO in two children

  • Open Access
  • Poster presentation

F Vanoni, A Von Scheven-Gête, M Hofer

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey

  • Open Access
  • Poster presentation

F Kara Eroglu, Y Bilginer, F Ozaltin, R Topaloglu, S Ozen

PReS-FINAL-2219: Evaluation of autonomic function in FMF

  • Open Access
  • Poster presentation

N Aktay Ayaz, N Melikoglu, G Keskindemirci, G Aydogan, O Isal Tosun, A Güzeltaş, E Odemis

PReS-FINAL-2220: Cochlear involvement in FMF

  • Open Access
  • Poster presentation

G Keskindemirci, N Aktay Ayaz, A Batioglu, G Aydogan, E Aldemir, Z Dönmez, Ö Yiğit, S Ozen

PReS-FINAL-2221: An earliest diagnosis of FMF

  • Open Access
  • Poster presentation

G Keskindemirci, N Aktay Ayaz, E Aldemir, C Aydogmus, G Aydogan, S Kavuncuoglu

PReS-FINAL-2222: FMF presenting with the features of malignancy

  • Open Access
  • Poster presentation

G Keskindemirci, N Aktay Ayaz, D Tugcu, A Akcay, E Aldemir, G Aydogan

PReS-FINAL-2223: The relationship between FMF, BD and epilepsy

  • Open Access
  • Poster presentation

H Sargsyan

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients

  • Open Access
  • Poster presentation

F Hofer, T Endres, B Kortus-Götze, N Blank, E Weißbarth-Riedel, C Schütz, T Kallinich, K Krause, C Rietschel, G Horneff, J Kuemmerle-Deschner

PReS-FINAL-2225: Oxidative stress in children with episodic fever of unknown origin

  • Open Access
  • Poster presentation

J Vojinovic, J Radovic, D Lazarevic, T Jeftic-Stoimenov, D Pavlovic

PReS-FINAL-2226: Assessment of autonomic functions in children with Familial Mediterranean Fever by using heart rate variability measurements

  • Open Access
  • Poster presentation

K Fidanci, M Gulgun, A Kilic, C Acikel, E Demirkaya, F Gok, S Ozen

PReS-FINAL-2227: QT and JT dispersion in children with FMF

  • Open Access
  • Poster presentation

K Fidanci, A Kilic, M Gulgun, C Acikel, G Basbozkurt, E Demirkaya, F Gok

PReS-FINAL-2228: Survey of off-label ANTI-IL1 treatments in France: two years data

  • Open Access
  • Poster presentation

L Rossi-Semerano, B Fautrel, D Wendling, E Hachulla, C Galeotti, A Meyer, S Ottaviani, R Dhote, O Richer, M Fouillet-Desjonqueres, I Touitou, I Koné-Paut

PReS-FINAL-2229: Pamidronate in CRMO - a small case series

  • Open Access
  • Poster presentation

M Schuller, J Franova, M Macku

PReS-FINAL-2230: A prospective evaluation of a cohort of patients with PFAPA syndrome

  • Open Access
  • Poster presentation

M Cattalini, I Bosio, A Meini, P Cancarini, M Berlucchi, G Savoldi

PReS-FINAL-2231: A series of 41 mutations of TNFRAF1A

  • Open Access
  • Poster presentation

MC Chastang, M Desjonqueres, V Hentgen, P Quartier Dit Maire, G Grateau, I Kone-Paut, I Durieu, J Ninet, P Cochat

PReS-FINAL-2232: Long-term follow-up in a national cohort of MKD patients: search for clinical predictors of a spontaneous improvement

  • Open Access
  • Poster presentation

M Doglio, S Federici, A Tommasini, A Meini, M Cattalini, L Obici, L Cantarini, F Zulian, L Breda, R Consolini, F Corona, A Insalaco, D Rigante, A Martini, M Gattorno

PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis

  • Open Access
  • Poster presentation

MM Kostik, IA Chikova, MF Dubko, LS Snegireva, VV Masalova, OV Kalashnikova, AY Mushkin, VG Chasnyk

PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome

  • Open Access
  • Poster presentation

O Kasapcopur, I Tugal-Tutkun, K Barut, T Erener-Ercan, A Gul

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report

  • Open Access
  • Poster presentation

R Caorsi, P Picco, A Buoncompagni, S Signa, F Minoia, S Federici, A Martini, M Gattorno

PReS-FINAL-2238: PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome: results from the Eurofever registry

  • Open Access
  • Poster presentation

R Caorsi, A Insalaco, D Marotto, J Frenkel, A Martini, F De benedetti, M Gattorno

PReS-FINAL-2239: Renal AA amyloidosis in a child with hyper-IgD syndrome and a novel MVK mutation

  • Open Access
  • Poster presentation

S Fingerhutova, A Kolsky, D Rowczenio, H Lachmann, Z Vernerova, F Votava, P Dolezalova

PReS-FINAL-2240: Serum amyloid protein a concentration in CAPS patients treated with anti IL1Β

  • Open Access
  • Poster presentation

S Pastore, G Paloni, M Gattorno, A Taddio, L Lepore

PReS-FINAL-2241: Cases of cryopyrin-associated periodic syndromes (CAPS) in one single rheumatologic center of Russia

  • Open Access
  • Poster presentation

SO Salugina, E Fedorov, N Kuzmina, E Zaharova

PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia

  • Open Access
  • Poster presentation

T Dallos, L Lukáčiková Gálová, E Macejková, N Toplak, M Debeljak, L Kovács

PReS-FINAL-2244: Ultrasound examination reveals typical alterations in joints of mucopolysaccharidosis (MPS) patients

  • Open Access
  • Poster presentation

N Karabul, M Beck, A Solyom, E Mengel, C Lampe

PReS-FINAL-2245: A rare case of subcutaneous panniculitis-like T cell lymphoma in a 9-month-old child

  • Open Access
  • Poster presentation

A Kozlova, D Abramov Dmitriy, N Miakova, A Maschan, A Shcherbina

PReS-FINAL-2246: CBCT versus orthopan tomogram detecting TMJ alteration in JIA

  • Open Access
  • Poster presentation

P Arvonen, J Naujokaityte, M Arvonen, J Niinimäki, P Vähäsalo, P Pirttiniemi

PReS-FINAL-2248: Parovirus B19 associated unusual joint symptoms in twin girls

  • Open Access
  • Poster presentation

H Sakalli, E Baskin, S Dener

PReS-FINAL-2250: Presentation of tuberculosis in patients using anti-TNFS drugs: report of 3 cases

  • Open Access
  • Poster presentation

BE Bica, LM Saldarriaga Rivera, H Tupinambá, MNL Azevedo

PReS-FINAL-2251: Influenza myositis outbreaks: clinical and laboratory findings

  • Open Access
  • Poster presentation

SP Cardin, TP Fernandes, JG Martin, LAL Resende, CS Magalhaes

PReS-FINAL-2253: A case series of HIV arthropathy in Cape Town

  • Open Access
  • Poster presentation

K Webb, C Scott, N Brice

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?

  • Open Access
  • Poster presentation

P Guddeti, Z Ahmed, M Yiallourides

PReS-FINAL-2255: Primary pyomiositis in children: a challenging diagnosis

  • Open Access
  • Poster presentation

V Moressa, S Pastore, M Pavan, C Bracaglia, L Lepore

PReS-FINAL-2256: Panniculitis revealing quantitative alpha 1 antitrypsine deficiency

  • Open Access
  • Poster presentation

A Gagro, N Pustišek, J Čepin Bogović, A Rožman, E Ozimec, AM Kapović

PReS-FINAL-2257: Pediatric rheumatology in a rare disease working group: examples of diagnoses

  • Open Access
  • Poster presentation

A Solyom, B Mosdósi, Z Nyul, K Komlósi

PReS-FINAL-2259: Spectrum of Sjögren syndrome in children

  • Open Access
  • Poster presentation

BE Bica, LM Saldarriaga Rivera, H Tupinambá, MNL Azevedo

PReS-FINAL-2261: Prevalence of orofacial symptoms and signs in patients with juvenile fibromyalgia

  • Open Access
  • Poster presentation

C Len, L Zwir, M Fraga, MT Terreri

PReS-FINAL-2262: Arthritis in a patient with type 1 glycogen storage disease

  • Open Access
  • Poster presentation

E Baskin, US Bayrakci, H Sakallı, A Kantarcı, F Ozcay

PReS-FINAL-2263: Progressive pseudorheumatoid dysplasia in differential diagnosis of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

E Vrtíková, E Košková, M Genčík, J Sedlákova

PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents

  • Open Access
  • Poster presentation

J Calzada-Hernández, A Noguera Julian, S Ricart Campos, R Bou Torrent, E Iglesias Jiménez, MI González Fernández, J Sánchez Manubens, V Torrente Segarra, L Rozas Quesada, FJ Martín Carpi, J Antón López

PReS-FINAL-2266: A rare cause for childhood uveitis: TINU (tubulointerstitial nephritis and uveitis) syndrome

  • Open Access
  • Poster presentation

K Barut, T Rızayev, A Yurt, I Tugal-Tutkun, S Çalışkan, N Canpolat, L Sever, O Kasapcopur

PReS-FINAL-2269: Incidence of antiphospholipid antibody syndrome in a cohort of children suffering from either arterial or venous thrombosis

  • Open Access
  • Poster presentation

P Cancarini, M Cattalini, I Bosio, M Marchini, S Vitari, A Meini

PReS-FINAL-2272: Association of benign joint hypermobility syndrome with mitral valve prolapsed in Iranian children

  • Open Access
  • Poster presentation

R Shiari, F Vaziri, E Zahmatkesh, H Javaherizadeh

PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience

  • Open Access
  • Poster presentation

S Murias Loza, RM Alcobendas Rueda, A Remesal Camba, D Pascual Salcedo, J Peralta, R Merino Muñoz

PReS-FINAL-2276: IgG4 related disease in a 10-year-old girl

  • Open Access
  • Poster presentation

S Pasic, G Ristic, S Djuricic

PReS-FINAL-2277: Clubbing fingers in a boy with arthritis

  • Open Access
  • Poster presentation

T Giani, G Vannucci, M Davide, E Marrani, A Paladini, G Simonini, I Pagnini, R Cimaz

PReS-FINAL-2278: Description of a Colombian cohort of patients with childhood systemic lupus erytematosus

  • Open Access
  • Poster presentation

AS Diaz Maldonado, A Monje Gaitan, F Gonzalez, N Gamba

PReS-FINAL-2279: Lupus nephritis in a Colombian cohort of pediatric patients

  • Open Access
  • Poster presentation

AS Diaz Maldonado, F Gonzalez, A Monje Gaitan, N Gamba

PReS-FINAL-2280: Lupus disease activity in a pediatric Colombian cohort with systemic lupus erytematosus

  • Open Access
  • Poster presentation

AS Diaz Maldonado, A Monje Gaitan, N Gamba, F Gonzalez

PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012

  • Open Access
  • Poster presentation

A Gazda, B Kołodziejczyk, M Wierzbowska, P Gietka, I Szczygielska, L Rutkowska-Sak, J Ząbek, B Wojciechowska, A Kraska

PReS-FINAL-2282: Amaurosis as a presenting sign of antiphospholipid syndrome secondary to systemic lupus erythematosus - case report

  • Open Access
  • Poster presentation

A Omerčahić-Dizdarević, S Mesihović-Dinarević, V Selmanovic (Mulaosmanovic), A Čengić

PReS-FINAL-2284: SLE and complement deficiencies: a French multicentric retrospective study

  • Open Access
  • Poster presentation

B Roland-Gosselin, E Allain-Launay, E Plouvier, L Mouthon, AL Fauchais, JC Lega, H Remeaux, P Cochat, M Desjonquères, M -H Said-Menthon, B Bader-Meunier, A Belot

PReS-FINAL-2286: Mastitis in an adolescent patient with juvenile systemic lupus erythematous

  • Open Access
  • Poster presentation

BE Bica, LMR Saldarriaga, ACP Rocha

PReS-FINAL-2287: Electroconvulsive therapy in a patient with juvenile systemic lupus erythematous

  • Open Access
  • Poster presentation

BE Bica, LMS Rivera, AN Nicol, GS Campos

PReS-FINAL-2289: Ovarian dysfunction in adult childhood-onset lupus patients: a possible role of methotrexate?

  • Open Access
  • Poster presentation

DB Araujo, LY Yamakami, E Bonfá, VS Viana, SG Pasoto, RM Pereira, PC Serafin, EF Borba, CA Silva

PReS-FINAL-2290: Is an abnormal lipid profile at diagnosis related to increased disease activity in JSLE patients

  • Open Access
  • Poster presentation

C Thorbinson, L Watson, C Roberts, MW Beresford

PReS-FINAL-2291: Activation of TLR pathway JSLE derived neutrophil extracellular traps

  • Open Access
  • Poster presentation

C Thorbinson, A Midgley, MW Beresford

PReS-FINAL-2292: Hypogonadism and osteoporosis among adolescents with systemic lupus erythematosus

  • Open Access
  • Poster presentation

D El-Ghoneimy, K Awwaad, E El-Hadidy, A Abdel-Latif

PReS-FINAL-2295: Correlations of health related quality of life reports completed by children with lupus and parents

  • Open Access
  • Poster presentation

LN Moorthy, E Roy, MG Peterson, AL Hassett, R Cuttica, C Magalhaes, J Sato, S Appenzeller, R Marini, C Len, M Vasco, S Oliveira, M Rodrigues, R Almeida, F Sztajnbok, L Campos, A Jesus, C Silva, E Faugier, L Cobian, A Quintero-Del-Rio, A Adams, L Barinstein, E Chalom, K Onel, J Lopez-Benitez, L Ray, K Haines, P Hashkes, V Cartwright, D Kingsbury, N Singer, I Tomanova-Soltys, S Hong, A Reiff, T Lehman

PReS-FINAL-2297: Atmospheric pollution: influence on disease activity in childhood-onset systemic lupus erythematosus patients

  • Open Access
  • Poster presentation

LM Campos, EGC Fernandes, CA Silva, AA Braga, AM Sallum, SCL Farhat

PReS-FINAL-2298: Biometrics of spleen and liver in patients with childhood-onset systemic lupus erythematosus

  • Open Access
  • Poster presentation

LM Campos, MF Silva, PF Tassetano, AG Alves, SM Rocha, M Valente, CA Silva

PReS-FINAL-2299: Novel biomarkers for the assessment of pediatric systemic lupus erythematosus nephritis (preliminary report)

  • Open Access
  • Poster presentation

A Koutsonikoli, M Trachana, V Tzimouli, E Farmaki, N Printza, A Garyfallos, V Galanopoulou, P Pratsidou-Gertsi, F Papachristou, F Kanakoudi-Tsakalidou

PReS-FINAL-2300: Shrinking lung syndrome in an adolescent male with juvenile systemic lupus erythematosus

  • Open Access
  • Poster presentation

M Rodrigues, A Teixeira, C Ferraz, I Brito

PReS-FINAL-2301: Cardiac tamponade and auto-immune haemolysis as first presentation of JSLE

  • Open Access
  • Poster presentation

M Yiallourides, J Shipman, S Rangaraj

PReS-FINAL-2302: Evaluation of magnetic resonance imaging abnormalities in juvenile neuro-psychiatric systemic lupus erythematosus

  • Open Access
  • Poster presentation

MRA Al-Obaidi, S Brown, L Ramsden, N Martin, D Saunders, C Pilkington, P Brogan, D Eleftheriou

PReS-FINAL-2304: Systemic lupus erythematosus in childhood: experience of single center (data of last ten years)

  • Open Access
  • Poster presentation

O Kasapcopur, S Sahin, K Barut, N Canpolat, S Caliskan, L Sever, N Arisoy

PReS-FINAL-2305: Erythema multiforme in a child with lupus - what's in a name?

  • Open Access
  • Poster presentation

R Khubchandani, AD Dhanrajani, DA Parikh

PReS-FINAL-2308: Catatonia due to systemic lupus erythematosus: characteristics and 36 months follow up of this rare manifestation of disease

  • Open Access
  • Poster presentation

V Selmanovic (Mulaosmanovic), T Avčin, S Mesihović-Dinarević, A Omerčahić-Dizdarević, L Oruč, S Zubčević, D Miličić-Pokrajac, D Anić, A Mornjaković-Franca, S Tanović, A Bučan-Varatanović, A Čengić

PReS-FINAL-2309: Juvenile systemic lupus erythematosus: a case series depiction in an urban community and a comparison to an adult case series

  • Open Access
  • Poster presentation

V Torrente-Segarra, E Iglesias, MI Gonzalez, J Sanchez, S Ricart, R Bou, T Salman-Monte, J Carbonell, J Antón-López

PReS-FINAL-2310: Successful rituximab treatment in a 14 year-old boy with lupus nephritis

  • Open Access
  • Poster presentation

V Torrente-Segarra, E Iglesias, R Bou, S Ricart, MI Gonzalez, J Sanchez, L Lopez-Vives, J Antón-López

PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis

  • Open Access
  • Poster presentation

G Mestrallet, A Faye, P Quartier, B Ranchin, P Cochat, A Belot

PReS-FINAL-2312: Cogan's syndrome: a diagnostic challenge. Report and review of the literature

  • Open Access
  • Poster presentation

A Lazareva, ZD Davidsone, R Santere, S Kuske, V Stanevicha

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis

  • Open Access
  • Poster presentation

B Koren, Š Blazina, N Toplak, D Ključevšek, T Avčin

PReS-FINAL-2315: Severe cutaneous vasculitis in two patients with juvenile idiopathic arthritis and biologic therapy

  • Open Access
  • Poster presentation

F Falcini, G Lepri, G Carnesecchi, F Bertini, M Matucci Cerinic

PReS-FINAL-2316: Churg-Strauss syndrome in a 17-year-old girl

  • Open Access
  • Poster presentation

G Ristic

PReS-FINAL-2317: Clinical presentation, management and outcome of Kawasaki disease (4 years reviews)

  • Open Access
  • Poster presentation

HM Benamer, Halima M Benamer, Brika Brwag

PReS-FINAL-2319: PED-BD cohort 2013: expert consensus classification gives higher sensitivity than the international study group criteria to define Behcet's disease in children

  • Open Access
  • Poster presentation

I Koné-Paut, M Darce Bello, F Shahram, S Ozen, R Cimaz, H Michael, M Gattorno, B Chkirate, K Bouayed, L Cantarini, J Anton, I Tugal-Tuktun, J Kummerle-Deschner, A Faye, S Benamour, TA Tran, A Arnoux

PReS-FINAL-2320: Different clinical presentation of takayasu arthritis: case report of two pediatric patients

  • Open Access
  • Poster presentation

I Rukavina, I Malčić, M Frković, M Jelušić

PReS-FINAL-2321: Clinical manifestations of granulomatosis with polyangiitis in 8 children from south-east region of Poland

  • Open Access
  • Poster presentation

J Kosałka, M Ignacak, A Zugaj, S Bazan-Socha, K Zachwieja, I Głodzik, G Lis, Z Żuber, J Musiał

PReS-FINAL-2322: Outcome of kidney transplantation in paediatric patients with ANCA associated glomerulonephritis: a single-center experience

  • Open Access
  • Poster presentation

M Twilt, D Noone, W Hayes, P Thorner, S Benseler, R Parekh, R Laxer, D Hebert

PReS-FINAL-2323: Cryoglobulinemic vasculitis preceding diagnosis of Carney complex

  • Open Access
  • Poster presentation

MB Glerup, C Heuck, J Bjerre, T Herlin

PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release

  • Open Access
  • Poster presentation

A Omenetti, R Caorsi, S Carta, L Delfino, F Penco, C Pastorino, F Schena, A Martini, A Rubartelli, M Gattorno

PReS-FINAL-2325: Different phenotypes associated with Q703K variant of the NLRP3 gene

  • Open Access
  • Poster presentation

A Von Scheven-Gête, M Hofer, G Simon, N Busso, M Morris, F Vanoni

PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret®) in patients with severe CAPS

  • Open Access
  • Poster presentation

M Wikén, P Gozzi, G Andersson, H Olivecrona, M Aldén Raboisson, T Kullenberg, M Leinonen, B Hallén

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis

  • Open Access
  • Poster presentation

D Moretti, T Giani, G Vannucci, E Marrani, G Simonini, I Pagnini, R Cimaz

PReS-FINAL-2328: Developing and validating the new severity score for FMF

  • Open Access
  • Poster presentation

E Demirkaya, C Acikel, A Gul, M Gattorno, E Ben-Chetrit, H Ozdogan, P Hashkes, A Polat, A Livneh, S Ozen

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)

  • Open Access
  • Poster presentation

M Piram, I Kone-Paut, H Lachmann, S Ozen, J Kuemmerle-Deschner, S Stojanov, A Simon, M Finetti, MP Sormani, A Martini, M Gattorno, N Ruperto

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS

  • Open Access
  • Poster presentation

J Antón, I Calvo, A Robles, J Yagüe, J Aróstegui, R Viana, S Bhansali, K Abrams

PReS-FINAL-2331: Low-penetrance NLRP3 variants

  • Open Access
  • Poster presentation

T Endres, F Hofer, R Goldbach-Mansky, HM Hoffman, N Blank, K Krause, C Rietschel, G Horneff, P Lohse, J Kuemmerle-Deschner

PReS-FINAL-2332: Activation-induced cell death of human monocytes as a novel mechanism fine-tuning inflammation and autoimmunity

  • Open Access
  • Poster presentation

M Miranda-García, J Däbritz, G Varga, T Weinhage, J Ehrchen, K Barczyk, J Roth, D Foell

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis

  • Open Access
  • Poster presentation

M Finetti, A Insalaco, L Cantarini, M D'Alessandro, A Meini, L Breda, M Alessio, P Picco, A Martini, M Gattorno

PReS-FINAL-2334: Chronic recurrent multifocal osteomyelitis and tnf-αlfa inhibitors

  • Open Access
  • Poster presentation

M Alberdi-Saugstrup, SM Nielsen

PReS-FINAL-2335: Preliminary analysis of 85 patients with mevalonate kinase deficiency from the eurofever registry

  • Open Access
  • Poster presentation

N Ter Haar, H Lachmann, P Woo, A Simon, A Meini, P Dolezalova, C Modesto, S Stojanov, B Bader-Meunier, A Insalaco, E Hoppenreijs, E Gallo, N Ruperto, J Frenkel, M Gattorno

PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome

  • Open Access
  • Poster presentation

N Rieber, A Brand, D Neri, T Hall, I Schäfer, S Hansmann, J Kümmerle-Deschner, D Hartl

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment

  • Open Access
  • Poster presentation

S Federici, J Frenkel, S Ozen, J Antòn, JI Arostegui, F De Benedetti, P Dolezalova, H Girschick, V Hentgen, M Hofer, H Lachmann, I Koné-Paut, J Kuemmerle-Deschner, B Neven, H Ozdogan, C Rose, A Simon, S Stojanov, N Toplak, I Touitou, R Vesely, P Woo, C Wouters, N Ruperto, A Martini, M Gattorno

PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment

  • Open Access
  • Poster presentation

A Tommasini, E Piscianz, E Valencic, E Cuzzoni, G Decorti, A Taddio

PReS-FINAL-2340: A pathogenic role for S100A8/A9 in experimental autoimmune arthritis

  • Open Access
  • Poster presentation

C Kessel, J Roth, D Foell, T Vogl

PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis

  • Open Access
  • Poster presentation

E Wehrens, S Vastert, G Mijnheer, J Meerding, M Klein, N Wulffraat, B Prakken, F van Wijk

PReS-FINAL-2345: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

G Giancane, S Pederzoli, X Norambuena, M Ioseliani, J Sato, MC Gallo, G Negro, N Ruperto, A Martini, A Ravelli

PReS-FINAL-2346: Hypomorphic RAG deficiencies: phenotypic variability and usefulness of TREC/KREC as diagnostic biomarkers

  • Open Access
  • Poster presentation

C Schuetz, U Pannicke, EM Jacobsen, M Honig, T Niehues, K Schwarz, AS Schulz

PReS-FINAL-2348: Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss

  • Open Access
  • Poster presentation

G Vannucci, E Berti, G Simonini, C Lunardi, C Bason, T Giani, I Pagnini, D Moretti, E Marrani, R Cimaz

PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies

  • Open Access
  • Poster presentation

M Rozic, A Trampus-Bakija, Z Rener-Primec, L Kitanovski, T Kveder, T Avcin

PReS-FINAL-2352: Apoptosis profile in patients with juvenile-onset systemic lupus erythematosus

  • Open Access
  • Poster presentation

B Liphaus, MH Kiss, S Carrasco, C Goldenstein-Schainberg

PReS-FINAL-2353: Are rasopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus?

  • Open Access
  • Poster presentation

B Bader-Meunier, H cave, N jeremiah, F Rieux-Laucat

PReS-FINAL-2355: Comparison of pediatric and adult SLE genetic load

  • Open Access
  • Poster presentation

MD Dominguez, ED Silverman, J Beyene

PReS-FINAL-2357: Effects of anti-melanocyte stimulating hormone in murine pristine-induced lupus

  • Open Access
  • Poster presentation

T Peixoto, S Mello, D Botte, S Carrasco, M Vendramini, C Goldenstein-Schainberg

PReS-FINAL-2358: T helper cells in henoch-schönlein purpura/iga vasculitis

  • Open Access
  • Poster presentation

B Gülhan, D Orhan, E Karabulut, F Özaltın, R Topaloğlu, A Düzova, S Özen

PReS-FINAL-2359: Renal involvement in hypocomplementemic urticarial vasculitis syndrome (huvs): report of 3 paediatric cases

  • Open Access
  • Poster presentation

C Bracaglia, A Aceti, M Vivarelli, A Insalaco, M Pardeo, R Nicolai, F De Benedetti, A Pasini

PReS-FINAL-2360: Severe disease course of pediatric-onset granulomatosis with polyangiitis as compared to adult patients: a long-term, single center, follow up study

  • Open Access
  • Poster presentation

G Minardo, V Carraro, G Martini, L Murer, F Vittadello, F Schiavon, F Zulian

PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis

  • Open Access
  • Poster presentation

M Twilt, R Schneider, D hebert, E harvey, R laxer, S dell, C licht, S benseler

PReS-FINAL-2363: Behçet's disease in children: the Great Ormond Street Hospital experience

  • Open Access
  • Poster presentation

S Nanthapisal, D Eleftheriou, Y Hong, N Klein, PA Brogan

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA

  • Open Access
  • Invited speaker presentation

P Livermore

PReS13-SPK-1034: looking for new monogenic forms of lupus

  • Open Access
  • Invited speaker presentation

Y Crow

PReS13-SPK-1283: Pathogenesis, diagnosis and management of neuropsychiatric SLE

  • Open Access
  • Invited speaker presentation

D Boumpas

PReS13-SPK-1033: Neonatal lupus

  • Open Access
  • Invited speaker presentation

R Cimaz

PReS13-SPK-1129: Biologic therapies in SLE

  • Open Access
  • Invited speaker presentation

DA Isenberg

PReS13-SPK-1137: New developments in our care & understanding of JIA

  • Open Access
  • Invited speaker presentation

MW Beresford

PReS13-SPK-1590: Relevance of cytokine in pediatric inflammatory disease

  • Open Access
  • Invited speaker presentation

F De Benedetti

PReS13-SPK-1472: Science of muscle training in inflammatory disease

  • Open Access
  • Invited speaker presentation

M Van Brussel

PReS13-SPK-1277: Role of ß2GPI in APS

  • Open Access
  • Invited speaker presentation

PP De Groot

PReS13-SPK-1592: Pediatric aspects of antiphospholipid syndrome

  • Open Access
  • Invited speaker presentation

T Avcin

PReS13-SPK-1322: Autoinflammatory in nature: what patients teach us

  • Open Access
  • Invited speaker presentation

M Gattorno

PReS13-SPK-1030: Juvenile dermatomyositis

  • Open Access
  • Invited speaker presentation

P Quartier

PReS13-SPK-1469: Juvenile scleroderma

  • Open Access
  • Invited speaker presentation

F Zulian

PReS13-SPK-1588: Recurrent fevers

  • Open Access
  • Invited speaker presentation

J Frenkel

PReS13-SPK-1028: Activity and damage - we have to measure them

  • Open Access
  • Invited speaker presentation

H Brunner

PReS13-SPK-1582: Activity and damage - we have to measure them

  • Open Access
  • Invited speaker presentation

BM Feldman

PReS13-SPK-1576: Unmeet needs in JIA treatment

  • Open Access
  • Invited speaker presentation

N Ruperto

PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases

  • Open Access
  • Invited speaker presentation

P Emery

PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases

  • Open Access
  • Invited speaker presentation

I Aksentijevich

PReS13-SPK-1292: Gut microbiome and metabolism

  • Open Access
  • Invited speaker presentation

H Tilg

PReS13-SPK-1107: Development of an academic pediatric rheumatology program

  • Open Access
  • Invited speaker presentation

R Laxer

PReS13-SPK-1127: Pediatric rheumatology in India

  • Open Access
  • Invited speaker presentation

RP Khubchandani

PReS13-SPK-1575: Science of pain amplification

  • Open Access
  • Invited speaker presentation

RF Howard

PReS13-SPK-1572: The therapy management of pain amplification syndrome

  • Open Access
  • Invited speaker presentation

S Maillard

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis

  • Open Access
  • Oral presentation

C Piper, H Varsani, K Arnold, L Wedderburn, C Mauri, K Nistala

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis

  • Open Access
  • Oral presentation

N Ruperto, DJ Lovell, K Jarosova, D Nemcova, V Vargová, H Michels, EC Chalom, N Ilowite, C Wouters, HI Brunner, KK Kracht, H Kupper, E Giannini, A Martini, N Mozaffarian

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA

  • Open Access
  • Oral presentation

M Tarkiainen, P Tynjälä, P Vähäsalo, P Lahdenne

PReS-FINAL-2004: Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study

  • Open Access
  • Oral presentation

F Sperotto, S Brachi, G Cuffaro, M Seguso, F Vittadello, F Zulian

PReS-FINAL-2173: Protein kinase C delta deficiency is a new cause of monogenic SLE

  • Open Access
  • Oral presentation

A Belot, PK Kasher, EW Trotter, AP Foray, AL Debaud, E Meffre, J Brognard, N Bonnefoy, Y Crow

PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children

  • Open Access
  • Oral presentation

E Sag, A Ravelli, ED Batu, A Tartaglione, AS Khalil, S Marks, S Ozen

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring

  • Open Access
  • Oral presentation

JB Woillard, B Bader-Meunier, R Salomon, B Ranchin, S Decramer, M Fischbach, E Berard, F Saint-Marcoux

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years

  • Open Access
  • Oral presentation

A Consolaro, S Lanni, F Minoia, S Davì, S Dalprà, B Schiappapietra, V Muratore, A Martini, A Ravelli

PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)

  • Open Access
  • Oral presentation

N Aikawa, C Goldenstein-Schainberg, M Vendramini, L Campos, C Saad, J Moraes, A Duarte, A Precioso, M Timenesky, E Bonfa, C Silva

PReS-FINAL-2178: Clinical and microarray follow-up of SJIA patients treated with anakinra over the past 10 years in a single institution

  • Open Access
  • Oral presentation

M Punaro, A Gotte, M Stoll, D Blankenship, F Allantaz, Z Xu, V Pascual

PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis

  • Open Access
  • Oral presentation

R Burgos-Vargas, S Tse, G Horneff, AL Pangan, K Unnebrink, JK Anderson

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH

  • Open Access
  • Oral presentation

F De Benedetti, N Ruperto, Z Zuber, R Cuttica, R Xavier, I Calvo, N Rubio, E Alekseeva, V Chasnyk, J Chavez, G Horneff, V Opoka-Winiarska, P Quartier, A Spindler, C Keane, K Bharucha, J Wang, D Lovell, A Martini, HI Brunner

PReS-FINAL-2181: Recombinant il-1ra restores the il-18-nk cell axis in steroid naive systemic juvenile idiopathic arthritis

  • Open Access
  • Oral presentation

W De Jager, SJ Vastert, G Mijnheer, BJ Prakken, NM Wulffraat

PReS-FINAL-2182: The role of murine rage in innate immune responses and inflammation: a systematic approach

  • Open Access
  • Oral presentation

T Wirth, C Kessel, T Weinhage, P Becker, N Nippe, D Foell

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate

  • Open Access
  • Oral presentation

N Ruperto, A Pistorio, S Knupp Feitosa de Oliveira, R Cuttica, A Ravelli, M Fischbach, B Magnusson, T Avcin, K Brochard, F Corona, G Couillault, F Dressler, V Gerloni, G Sterba, F Zulian, MT Apaz, A Cespedes-Cruz, R Cimaz, C Bracaglia, R Joos, P Quartier, R Russo, M Tardieu, N Wulffraat, S Angioloni, A Martini

PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis

  • Open Access
  • Oral presentation

D Jadon, LP Hunt, R Arumugam, AV Ramanan, R Sengupta

PReS-FINAL-2186: Monoallelic mutations of familial hlh-related genes associated to macrophage activation syndrome

  • Open Access
  • Oral presentation

C Bracaglia, E Sieni, V Cetica, M Da Ros, A Insalaco, C De Fusco, C Micalizzi, F De Benedetti, M Aricò

PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome

  • Open Access
  • Oral presentation

M Cruikshank, P Anoop, O Nikolajeva, A Rao, K Rao, K Gilmour, D Eleftheriou, PA Brogan

PReS-FINAL-2188: Insulin sensitivity is improved in sjia children with insulin resistance after tocilizumab treatment: results from the tender study

  • Open Access
  • Oral presentation

H Mirjafari, N Ruperto, HI Brunner, Z Zuber, F Zulian, MR Maldonado-Velázquez, E Mantzourani, K Murray, J Roth, J Rovensky, O Vougiouka, J Wang, O Harari, D Lovell, A Martini, F De Benedetti

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy

  • Open Access
  • Poster presentation

K Yamazaki, M Kikuchi, T Nozawa, T Kanetaka, R Hara, T Imagawa, K Nishimura, N Sakurai, T Sato, S Yokota

PReS-FINAL-2190: Validation of the new histopathological classification of anca glomerulonephritis and its association with renal outcomes in a paediatric population

  • Open Access
  • Oral presentation

M Twilt, D Noone, W Hayes, P Thorner, S Benseler, R Parekh, R Laxer, D Hebert

PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases

  • Open Access
  • Oral presentation

J Wipff, D Nouar, I Lemelle, C Pajot, A Duquesne, M Lorrot, A Faye, B Bader-Meunier, K Brochard, V Despert, S Jean, M Grall-Lerosey, Y Marot, A Pagnier, P Quartier, C Deslandre

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis

  • Open Access
  • Oral presentation

C Ferrari, GC Varnier, A Consolaro, D Marafon, C Pilkington, S Maillard, M Jelusic-Drazic, A Civino, A Martini, A Ravelli

PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers

  • Open Access
  • Oral presentation

S Federici, S Ozen, I Koné-Paut, H Lachmann, P Woo, L Cantarini, G Amaryan, A Insalaco, J Kuemmerle-Deschner, B Neven, N Dewarrat, Y Uziel, D Rigante, T Herlin, S Martino, A Simon, S Stojanov, H Ozdogan, J Frenkel, N Ruperto, A Martini, MP Sormani, M Hofer, M Gattorno

PReS-FINAL-2366: Paediatric rheumatology in South Africa

  • Open Access
  • Oral presentation

C Scott

PReS-FINAL-2367: Academic training of pediatric rheumatologist in the Russian federation

  • Open Access
  • Oral presentation

E Alekseeva, E Chistyakova

PReS-FINAL-2368: A, B, C, don't ever forget the joints

  • Open Access
  • Oral presentation

W Abusrewil, A Whiteley, A-M McMahon, M Al-Obaidi

PReS-FINAL-1013: Magnetic resonance imaging as a non-invasive tool to assess muscle edema in juvenile dermatomyositis. Return to normal after treatment

  • Open Access
  • Poster presentation

E Iglesias, M Navallas, L Riaza, V Torrente-Segarra, R Bou, S Ricart, MI González, J Sánchez, J Antón

PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis

  • Open Access
  • Poster presentation

J Sanchez-Manubens, E Iglesias, C Jou, MI Gonzalez, R Bou, V Torrente-Segarra, S Ricart, J Calzada-Hernandez, J Anton

PReS-FINAL-1015: A systematic literature review on diagnosis and treatment of pediatric rheumatic diseases: a shared initiative

  • Open Access
  • Poster presentation

V Boom, N de Graeff, F Belutti Enders, N Groot, N ter Haar, F Sperotto, S Vastert, N Wulffraat

PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity

  • Open Access
  • Poster presentation

A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri, LR Wedderburn, Y Ioannou

PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?

  • Open Access
  • Poster presentation

S De Leeuw, B Thirugnanabalan, H Varsani, F Warden, N Makengo, J Lewis, A Pesenacker, L Wedderburn

PReS-FINAL-1019: Inflammatory monocytes induce resistance of effector t cells to suppression

  • Open Access
  • Poster presentation

EJ Wehrens, A Boltjes, M Klein, SJ Vastert, BJ Prakken, F Van Wijk

PReS-FINAL-1021: Further characterization of CD161+ regulatory t cells in health and disease

  • Open Access
  • Poster presentation

CL Duurland, G Chain, RF O'Shaughnessy, AM Pesenacker, LR Wedderburn

PReS-FINAL-2006: Resilience and coping in adolentes with rheumatic illness

  • Open Access
  • Poster presentation

M Alessio, F Fontana, A Officioso, S Cotini, F Fontana, C Forni, M Alessio

PReS-FINAL-2089: Temporomandibular joint involvement and quality of life in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

P Frid, E Nordal, F Bovis, D Marafon, D De Angelis, S Oliveira, G Simonini, F Corona, J Davidson, H Foster, R Joos, I Foeldvari, M Steenks, P Lahdenne, P Dolezalova, E Palmisani, A Martini, A Pistorio, N Ruperto

PReS-FINAL-2091: Extra-articular calcification after intra-articular corticosteroid injection

  • Open Access
  • Poster presentation

P Toftedal, LA Bistrup, AE Christensen

PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases

  • Open Access
  • Poster presentation

P Salvati, S Callegari, G Tripodi, MB Michelis, S Boero, R Lorini, MG Alpigiani

PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?

  • Open Access
  • Poster presentation

P Pratsidou-Gertsi, E Verykouki, G Pardalos, M Trachana

PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients

  • Open Access
  • Poster presentation

R Marques, F Ramos, I Perpétuo, S Fernandes, C Furtado, AF Mourão, F Martins, H Canhão, JE Fonseca, JA Pereira da Silva

PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept

  • Open Access
  • Poster presentation

R Nicolai, E Cortis, L Ravà, C Bracaglia, M Pardeo, A Insalaco, PS Buonuomo, F De Benedetti, AE Tozzi

PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

SN Baydogan, E Tarakcı, O Kasapcopur

PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients

  • Open Access
  • Poster presentation

S Verazza, A Consolaro, A Frisina, G Conti, D Rigante, C Robbiano, MG Alpigiani, A Ravelli

PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

S Vastert, M Bulatovic-Calasan, R Scholman, M Klein, N Wulffraat, B Prakken, FV Wijk

PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA

  • Open Access
  • Poster presentation

S Davì, F Minoia, AC Horne, E Demirkaya, N Ilowite, A Insalaco, M Ioseliani, M Jelusic-Drazic, MA Kapovic, O Kasapcopur, I Kone-Paut, L Lepore, C Li, S Magni-Manzoni, D Maritsi, D Mccurdy, R Merino, P Miettunen, N Ruperto, A Martini, RQ Cron, A Ravelli

PReS-FINAL-2103: Real life management of VZV infection or reactivation in rheumatic children on biologics: the French experience

  • Open Access
  • Poster presentation

S Guillaume-Czitrom, V Remy-Piccolo, A Duquesne, I Kone-Paut, M Grall, E Allain-Launay, R Dagher, A Faye, K Brochard, E Grouteau, C Pietrement, L Rossi, P Quartier, J Morel

PReS-FINAL-2106: Clinical psoriatic arthritis of specific children

  • Open Access
  • Poster presentation

S Chebisheva, A Meleshkina

PReS-FINAL-2107: In vitro investigation into mesenchymal stromal cells as a potential therapeutic in juvenile arthritis

  • Open Access
  • Poster presentation

J Wienke, S De Roock, J Swart, A Martens, N Wulffraat, B Prakken

PReS-FINAL-2108: Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan

  • Open Access
  • Poster presentation

T Miyamae, E Tanaka, T Kishi, T Matsuyama, T Igarashi, S Fujikawa, A Taniguchi, S Momohara, S Nagata, H Yamanaka

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis

  • Open Access
  • Poster presentation

TH Reinards, H Albers, D Brinkman, S Kamphuis, M Van Rossum, E Hoppenreijs, H Girschick, C Wouters, R Saurenmann, R Toes, T Huizinga, J Houwing-Duistermaat, M Schilham, R Ten Cate

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy

  • Open Access
  • Poster presentation

T Sato, K Nishimura, T Nozawa, T Kanetaka, M Kikuchi, R Hara, N Sakurai, K Yamazaki, Y Takeuchi, S Yokota

PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics

  • Open Access
  • Poster presentation

V Remy Piccolo, S Sotou-Bere, A Woerner, R Mouy, B Florkin, B Bader-Meunier, P Quartier

PReS-FINAL-2113: The association of the NFKB1 gene polymorphism with systemic onset juvenile idiopathic arthritis in Russia

  • Open Access
  • Poster presentation

VA Malievsky, TV Viktorova, KV Danilko, LS Nazarova

PReS-FINAL-2114: The leptin and adiponectin as biomarkers of atherosclerosis in juvenile rheumatic arthritis

  • Open Access
  • Poster presentation

V Opoka-Winiarska, J Tabarkiewicz, A Emeryk

PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project

  • Open Access
  • Poster presentation

WA Sifuentes Giraldo, CA Guillén Astete, ML Gámir Gámir, C Arnal Guimerá, D Clemente Garulo, I Calvo, I Rotes, J Sampedro Álvarez, J García Consuegra, M Medrano, P Collado, R Roldán, S Bustabad

PReS-FINAL-2116: Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists

  • Open Access
  • Poster presentation

W Armbrust, J Kaak, J Bouma, O Lelieveld, N Wulffraat, P Sauer, E van Sonderen

PReS-FINAL-2118: Painless contractures of fingers in a female child

  • Open Access
  • Poster presentation

A Gagro, AM Kapović, M Žutelija Fattorini, G Krakar, G Roić

PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma

  • Open Access
  • Poster presentation

DP Hawley, CE Pain, EM Baildam, HE Foster

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes

  • Open Access
  • Poster presentation

G Cuffaro, G Martini, F Sperotto, T Avcin, R Russo, O Kasapcopur, F Vittadello, F Zulian

PReS-FINAL-2122: Autologous stem cell transplantation in a patient with severe systemic sclerosis in Portugal

  • Open Access
  • Poster presentation

M Guedes, C Zilhão, L Palhau, I Almeida, I Silva, C Vasconcelos, A Marinho, C Vaz, A Campos

PReS-FINAL-2123: Feto-maternal outcome in patients with systemic sclerosis

  • Open Access
  • Poster presentation

SE Maher, FM Ismail

PReS-FINAL-2124: Electromyography assessment in localized scleroderma

  • Open Access
  • Poster presentation

TP Fernandes, TD Fernandes, LFB Angulski, LAL Resende, CS Magalhaes

PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome

  • Open Access
  • Poster presentation

T Kishi, T Miyamae, A Seki, M Shioda, K Ishigaki, R Morimoto, N Ishiguro, Y Hamaguchi, M Fujimoto, Y Kawaguchi, H Yamanaka, S Nagata

PReS-FINAL-2126: How to follow up children with Raynaud syndrome - recommendations based on the Hamburg consensus meeting 2012

  • Open Access
  • Poster presentation

T Constantin, C Pain, N Toplak, M Moll, I Konert, DP Piotto, NA Ayaz, D Nemkova, P Hoeger, M Cutolo, V Smith, I Foeldvari

PReS-FINAL-2127: Sclerodermatous graft versus host disease

  • Open Access
  • Poster presentation

JR Stevenson, C Mcvitty, N Martin, B Gibson, AM Ewins, L Jones, D Shanks, C Grant, M Berry, J Duncan, JE Davidson

PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients

  • Open Access
  • Poster presentation

R Culpo, M Ricca, F Vittadello, G Sequi, F Zulian, G Martini

PReS-FINAL-2129: Whole-body versus localized magnetic resonance imaging in the assessment of juvenile dermatomyositis

  • Open Access
  • Poster presentation

A Madeo, MB Damasio, M Dellepiane, A Providenti, D Beleva, A Buoncompagni, A Beltramo, N Ruperto, A Martini, C Malattia

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease

  • Open Access
  • Poster presentation

E Moraitis, S Tansley, K Arnold, ZE Betteridge, H Gunawardena, TS Jacques, C Owens, LR Wedderburn, N Mchugh

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis

  • Open Access
  • Poster presentation

F Bellutti Enders, A Van Royen-Kerkhof, B Prakken, F Van Wijk, R Scholman, W De Jager

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs

  • Open Access
  • Poster presentation

A Consolaro, S Verazza, MC Gallo, G Bracciolini, G Negro, A Frisina, N Ruperto, A Martini, A Ravelli

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

A Woerner, F Uettwiller, I Melki, B Bader-Meunier, R Mouy, C Wouters, P Quartier

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial

  • Open Access
  • Poster presentation

C Malattia, N Ruperto, E Palmisani, S Pederzoli, A Pistorio, HI Brunner, R Cuttica, I Calvo, SM Garay, D Eleftheriou, C Wouters, J Wang, C Devlin, D Lovell, A Martini, F De Benedetti, A Ravelli

PReS-FINAL-2135: Analysis of the HLA region in a large cohort of juvenile idiopathic arthritis cases identifies independent effects at HLA-DRB1

  • Open Access
  • Poster presentation

A Hinks, J Cobb, B Han, MC Marion, M Sudman, P Martin, J Bohnsack, LR Wedderburn, JP Haas, PI De Bakker, CD Langefeld, S Raychaudhuri, S Prahalad, SD Thompson, W Thomson

PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

ES Zholobova, OU Konopelko, LA Galstyan, OS Rozvadovskaya, MN Nikolaeva

PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

  • Open Access
  • Poster presentation

F De Benedetti, N Ruperto, HI Brunner, A Grom, N Wulffraat, M Henrickson, R Jerath, Y Kimura, AK Kadva, J Wang, A Martini, D Lovell

PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)

  • Open Access
  • Poster presentation

F De Benedetti, HI Brunner, E Baildam, R Burgos-Vargas, G Horneff, HI Huppertz, K Minden, BL Myones, K Onel, J Wang, K Bharucha, D Lovell, A Martini, N Ruperto

PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey

  • Open Access
  • Poster presentation

F Minoia, S Davì, A Horne, A Consolaro, S Rosina, Z Davidsone, C De Cunto, J De Inocencio, E Eisenstein, G Espada, M Fishbach, M Frosch, R Gallizzi, ML Gamir, T Griffin, A Grom, T Hennon, G Horneff, Z Huasong, N Ruperto, A Martini, RQ Cron, A Ravelli

PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)

  • Open Access
  • Poster presentation

F Perfetti, F Gesualdo, V Messia, A Insalaco, C Bracaglia, M Pardeo, R Nicolai, L Meli, F De Benedetti, S Magni Manzoni

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

  • Open Access
  • Poster presentation

G Negro, A Consolaro, S Verazza, G Bracciolini, S Rosina, R Pignataro, A Civino, A Martini, A Ravelli

PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept

  • Open Access
  • Poster presentation

G Susic, G Radunovic, N Damjanov, D Novakovic, N Djurovic, R Stojanovic

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

J Anink, MH Otten, LA Van Suijlekom-Smit, MA Van Rossum, KM Dolman, EP Hoppenreijs, R Ten Cate, T Vogl, D Foell, J Roth, D Holzinger

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register

  • Open Access
  • Poster presentation

MH Otten, J Anink, FH Prince, M Twilt, SJ Vastert, R Ten Cate, EP Hoppenreijs, W Armbrust, SL Gorter, PA Van Pelt, S Kamphuis, KM Dolman, JF Swart, JM Van den Berg, Y Koopman-Keemink, MA Van Rossum, NM Wulffraat, LA Van Suijlekom-Smit

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

JF Swart, S De Roock, NM Wulffraat

PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

JA Ellis, KJ Scurrah, RA Chavez, AL Ponsonby, A Pezic, RC Allen, JD Akikusa, JE Munro

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis

  • Open Access
  • Poster presentation

K Walscheid, M Hennig, C Heinz, D Bauer, M Dietzel, M Busch, S Wasmuth, D Foell, C Deeg, A Heiligenhaus

PReS-FINAL-2151: HLA B27/B7, TLR-4, NLRP3, CXCR4 AND PTPN12: the shared genetic master-key genes leading to development of undifferentiated spondyloarthritis/era in children

  • Open Access
  • Poster presentation

L Lamot, M Vidović, L Tambić Bukovac, F Borovečki, K Gotovac, F Bingula, M Harjaček

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M Lavric, T Weinhage, J Klotsche, G Horneff, JP Haas, K Minden, D Foell

PReS-FINAL-2153: Intestinal gamma/delta- T cells are upregulated in children with active uveitis

  • Open Access
  • Poster presentation

M Arvonen, P Vähäsalo, T Karttunen

PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases

  • Open Access
  • Poster presentation

MM Kostik, NN Abramova, LS Snegireva, LI Vasykina, MF Dubko, VV Masalova, TL Kornishina, TS Likhacheva, IA Chikova, NI Glebova, NV Buchinskaya, OV Kalashnikova, VG Chasnyk

PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

M Zajc Avramovič, N Toplak, M Debeljak, M Accetto, L Lusa, V Dolžan, T Avcin

PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy

  • Open Access
  • Poster presentation

N Nirmala, N Wulffraat, H Brunner, P Quartier, R Brik, L Mccann, H Ozdogan, L Rutkowska-Sak, R Schneider, V Gerloni, L Harel, M Terreri, K Houghton, R Joos, D Kingsbury, J Lopez-Benitez, S Radominski, A Brachat, S Bek, M Schumacher, M Valentin, H Gram, K Abrams, A Martini, N Ruperto, D Lovell

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

  • Open Access
  • Poster presentation

P Quartier, H Brunner, T Constantin, S Padeh, I Calvo, M Erguven, L Goffin, M Hofer, T Kallinich, S Oliveira, Y Uziel, S Viola, K Nistala, C Wouters, K Lheritier, J Hruska, K Abrams, A Martini, N Ruperto, D Lovell

PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients

  • Open Access
  • Poster presentation

P Quartier, N Ruperto, N Wulffraat, H Brunner, R Brik, L Mccann, H Foster, M Frosch, V Gerloni, L Harel, C Len, K Houghton, R Joos, K Abrams, K Lheritier, S Kessabi, A Martini, D Lovell

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients

  • Open Access
  • Poster presentation

P Lu, J Hsu, C Keane, S Fettner, J Wang, N Ruperto, O Harari, HI Brunner, F De Benedetti

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study

  • Open Access
  • Poster presentation

PC Hissink Muller, PM Westedt, AE Budding, CF Allaart, DM Brinkman, TW Kuijpers, JM Van den Berg, LW Van Suijlekom-Smit, MA Van Rossum, TG De Meij, R Ten Cate

PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

P Van Dijkhuizen, M Bulatovic-Calasan, S Pluijm, M De Rotte, B Vastert, S Kamphuis, R De Jonge, N Wulffraat

PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up

  • Open Access
  • Poster presentation

R Marques, F Ramos, AF Mourão, F Martins, H Canhão, JE Fonseca, JA Pereira da Silva

PReS-FINAL-2164: Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

R Pignataro, AL Rodriguez-Lozano, G Giancane, S Viola, M Valle, S Gregorio, X Norambuena, M Ioseliani, A Pistorio, A Martini, A Ravelli

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

S Pastore, V Moressa, G Stocco, G Decorti, L Lepore

PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis?

  • Open Access
  • Poster presentation

S Lanni, F Bovis, C Papadopoulou, M Kostik, MI Gonzalez-Fernandez, M Bohm, JC Nieto-Gonzalez, M Bertamino, A Martini, A Ravelli

PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0

  • Open Access
  • Poster presentation

WA Sifuentes Giraldo, C Guillén Astete, ML Gámir Gámir, S Pérez Vicente, L Carmona, JJ Gómez-Reino

PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis

  • Open Access
  • Poster presentation

Y Xiong, W Wang, W Ebling, H Sun, O Luttringer, K Abrams, N Ruperto, H Brunner

PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)

  • Open Access
  • Poster presentation

C Goldenstein-Schainberg, J Gordo, R Krieger, LE Paula, N Aikawa

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis

  • Open Access
  • Poster presentation

M Kikuchi, T Nozawa, T Kanetaka, K Nishimura, R Hara, K Yamazaki, T Sato, N Sakurai, S Yokota

PReS-FINAL-2195: The comparison of the efficacy of once and twice daily dosage of colchicine in pediatric patients with Familial Mediterranean Fever

  • Open Access
  • Poster presentation

A Polat, C Acikel, B Sozeri, I Dursun, O Kasapcopur, H Peru, I Dokurel, H Poyrazoglu, S Bakkaloglu, A Delibas, Z Ekinci, NA Ayaz, Y Kandur, E Unsal, B Makay, F Gok, S Ozen, E Demirkaya

PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study

  • Open Access
  • Poster presentation

A Naselli, L Cantarini, A Insalaco, M Alessio, A Tommasini, R Gallizzi, S Signa, OM Lucherini, F Caroli, I Ceccherini, A Martini, M Gattorno

PReS-FINAL-2197: Teenage boy suffering from diabetes mellitus type 1 and heterozygous Familial Mediterranean Fever: a case report

  • Open Access
  • Poster presentation

AN Olivieri, MF Gicchino, C Granato, A Mauro, A Mellos

PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease

  • Open Access
  • Poster presentation

A Kozlova, D Abramov, N Miakova, A Maschan, A Shcherbina

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS

  • Open Access
  • Poster presentation

A Insalaco, G Prencipe, PS Buonuomo, I Ceccherini, C Bracaglia, M Pardeo, R Nicolai, F De Benedetti

PReS-FINAL-2200: Phenotype of V198M and Q703K NLRP3 variants

  • Open Access
  • Poster presentation

V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti, A Insalaco

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient

  • Open Access
  • Poster presentation

M Pardeo, E Cortis, C Bracaglia, R Nicolai, F De Benedetti, A Insalaco

PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome

  • Open Access
  • Poster presentation

A Insalaco, V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti

PReS-FINAL-2203: Assessment of sleep problems in children with familial Mediterranean fever

  • Open Access
  • Poster presentation

B Makay, SK Kılıçarslan, A Anık, E Ünsal

PReS-FINAL-2204: Developing of a new scale for assessing the adherence to colchicines treatment in pediatric patients with FMF

  • Open Access
  • Poster presentation

S Yesilkaya, C Acıkel, B Eren Fidanci, B Sozeri, N Aktay Ayaz, N Akıncı, G Ozcelik, S Kavukcu, Ü Aydogan, S Ozenc, S Emre, O Donmez, S Yuksel, A Delibas, A Berdelli, H Poyrazoglu, M Saldir, N Cakar, H Peru, S Bakkaloglu, Y Tabel, O Sari, A Polat, G Basbozkurt, E Unsal, F Gok, O Kasapcopur, S Ozen, E Demirkaya

PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF

  • Open Access
  • Poster presentation

B Sozeri, S Mir, K Ozdemir, A Berdeli

PReS-FINAL-2206: Clinical experiences in patients with chronic recurrent multifocal osteomyelitis (CRMO)

  • Open Access
  • Poster presentation

B Sozeri, B Yildiz, M Sezak, M Argin

PReS-FINAL-2207: Results from a multicenter international registry of Familial Mediterranean Fever: validation of the new set of pediatric diagnostic criteria

  • Open Access
  • Poster presentation

E Demirkaya, S Ozen, C Saglam, T Turker, A Duzova, P Woo, I Konè-Paut, M Doglio, G Amarian, J Frenkel, Y Uziel, A Insalaco, L Cantarini, M Hofer, S Boiu, C Modesto, A Bryant, D Rigante, E Papadopoulou-Alataki, S Guillaume-Czitrom, N Ruperto, M Gattorno

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Von einer Mandelallergie, die keine mehr war

Ein zweijähriger Junge mit bekannter Mandelallergie und auffälligen Reaktionen auf Mückenstiche soll auf weitere Allergien getestet werden – eigentlich ein klarer Fall. Doch ein unerwartet erhöhter Tryptase-Wert lässt den Kinderpneumologen aufhorchen. Was steckt hinter diesem Laborergebnis?

Konjunktivaler Provokationstest gelingt leicht in der Praxis

Die aktualisierte S2k-Leitlinie zur Provokationstestung bei allergischen oberen Atemwegserkrankungen steht kurz vor der Verabschiedung. Hinzugekommen ist nun auch die konjunktivale Provokation.

Unkontrolliertes Asthma: Welches Biologikum beim Kind?

Bevor ein Kind mit unkontrolliertem Asthma ein Biologikum erhält, muss zunächst klar sein, dass die Diagnose stimmt. Die Auswahl hängt dann nicht nur vom Zulassungsstatus ab, sondern auch vom jeweiligen Asthma-Phänotyp.

Knoten im Blasenkatheter – und jetzt?

Einem sechsjährigen Jungen wird aufgrund einer operativen Korrektur einer Hypospadie ein Blasenkatheter gelegt. Zehn Tage später soll der Katheter entfernt werden – doch er sitzt fest. So löste das Team das Problem.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Mandeln in und neben einem Holzschälchen/© onairjiw / Getty Images / iStock (Symbolbild), Kind erhält Augentropfen/© Nadzeya Haroshka / Getty Images / iStock (Symbolbild mit Fotomodell), Kind benutzt Inhalator gegen Asthma/© M. Dykstra / Fotolia (Symbolbild mit Fotomodell), Urinkatheter/© Sherry Young / stock.adobe.com